Meluadrine
Overview of the medication Meluadrine
Meluadrine | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Meluadrine is a medication used primarily in the management of certain cardiovascular diseases. It is classified as a beta-adrenergic agonist, which means it works by stimulating beta-adrenergic receptors in the heart and other tissues.
Mechanism of Action[edit | edit source]
Meluadrine functions by activating beta-adrenergic receptors, which are part of the sympathetic nervous system. This activation leads to an increase in cyclic adenosine monophosphate (cAMP) within cells, resulting in enhanced cardiac output and bronchodilation. The primary effect of Meluadrine is to increase the force of myocardial contraction, making it useful in conditions where increased cardiac output is desired.
Medical Uses[edit | edit source]
Meluadrine is indicated for the treatment of various cardiovascular conditions, including:
It is also sometimes used off-label for the management of asthma due to its bronchodilatory effects.
Side Effects[edit | edit source]
Common side effects of Meluadrine include:
In rare cases, it may cause more severe reactions such as arrhythmias or myocardial ischemia.
Pharmacokinetics[edit | edit source]
Meluadrine is typically administered intravenously, allowing for rapid onset of action. It is metabolized in the liver and excreted primarily through the kidneys. The half-life of Meluadrine is relatively short, necessitating continuous infusion for sustained therapeutic effects.
Contraindications[edit | edit source]
Meluadrine should not be used in patients with:
- Known hypersensitivity to the drug
- Pheochromocytoma
- Uncontrolled hypertension
Interactions[edit | edit source]
Meluadrine may interact with other medications, including:
- Beta-blockers, which can antagonize its effects
- Monoamine oxidase inhibitors (MAOIs), which can potentiate its effects
- Tricyclic antidepressants, which may increase the risk of cardiovascular side effects
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD